Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-13-001531
Filing Date
2013-03-28
Accepted
2013-03-28 16:12:56
Documents
13
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT dara_10k.htm 10-K 2736555
2 EXHIBIT 21 dara_ex21.htm EX-21 4396
3 EXHIBIT 23.1 dara_ex231.htm EX-23.1 2830
4 EXHIBIT 23.2 dara_ex232.htm EX-23.2 9964
5 EXHIBIT 31.1 dara_ex311.htm EX-31.1 9515
6 EXHIBIT 31.2 dara_ex312.htm EX-31.2 10119
7 EXHIBIT 32 dara_ex32.htm EX-32 7164
  Complete submission text file 0001354488-13-001531.txt   8494866

Data Files

Seq Description Document Type Size
8 dara-20121231.xml EX-101.INS 1053323
9 dara-20121231.xsd EX-101.SCH 70411
10 dara-20121231_cal.xml EX-101.CAL 68980
11 dara-20121231_lab.xml EX-101.LAB 427976
12 dara-20121231_pre.xml EX-101.PRE 289467
13 dara-20121231_def.xml EX-101.DEF 134197
Mailing Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615
Business Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615 919-861-0202
DARA BioSciences, Inc. (Filer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23776 | Film No.: 13724132
SIC: 2834 Pharmaceutical Preparations